- Exchanges
- BSE, NSE
- Industry
- Hospital
- Issue
- Book building
Jupiter Life Line Hospitals IPO
₹1,075.75
+46.36% on listing
Listing-day close · NSE · 18 Sep 2023 · issue price ₹735
Jupiter Life Line Hospitals’ ₹869 crore IPO was priced at ₹735 a share. It listed on the NSE on 18 Sep 2023 and closed its first day at ₹1,075.75, up 46.36% on the issue price.
Timeline
- Opens
- Closes
- Allotment
- Refunds
- Shares in demat
- Listing
Issue details
- Issue size
- ₹869 Cr
- Fresh issue
- ₹542 Cr
- Offer for sale
- ₹327 Cr
- Lot size
- 20 shares
- Minimum investment
- ₹14,700
- Face value
- ₹10
- Registrar
- Kfin Technologies
Subscription
| Category | Shares offered | Times subscribed |
|---|---|---|
| Total | — | 46.01× |
Overall, from the basis of allotment.
Financials and valuation
- Market cap (post-issue)
- ₹4,819 Cr
- P/E (post-issue)
- 66.1
- ROE
- 20.03%
- ROCE
- 20.94%
- PAT margin
- −0.47%
- Promoter holding
- 49.79% → 40.91%
From the offer documents.
Listing
- Listing date
- 18 Sep 2023
- Issue price
- ₹735
- Open
- ₹973.00
- High
- ₹1,108.95
- Low
- ₹970.00
- Close
- ₹1,075.75
Listing day on the NSE. The close was +46.36% on the issue price.
JLHL share price todayFAQs
When did the Jupiter Life Line Hospitals IPO open and close?
It opened on 6 Sep 2023 and closed on 8 Sep 2023.
What was the Jupiter Life Line Hospitals IPO price?
The price band was ₹695–735 a share. The final issue price was ₹735.
What is the lot size and minimum investment?
One lot is 20 shares, ₹14,700 at ₹735 a share. Retail investors apply in whole lots.
How much did Jupiter Life Line Hospitals raise?
₹869 crore: ₹542 crore of new shares and ₹327 crore offered by existing shareholders.
How many times was the Jupiter Life Line Hospitals IPO subscribed?
46.01 times overall.
How did Jupiter Life Line Hospitals list?
It listed on the NSE on 18 Sep 2023 at ₹973.00 and closed the day at ₹1,075.75, up 46.36% on the ₹735 issue price.
Who is the registrar of the Jupiter Life Line Hospitals IPO?
Kfin Technologies handles the allotment, refunds and credit of shares.
For information only. Not investment advice or a research report.
Full disclaimerSee how an IPO fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app